The FDA just approved Cosentyx (secukinumab) for Hidradenitis Suppuritiva (HS). Hidrandenitis Suppurativa is a painful, long-term skin condition that causes skin abscesses and scarring.  This is one of the newest drugs approved for the condition.  Cosentyx is used in many other conditions including ankylosing spondylitis, psoriasis, and psoriatic arthritis.